Amedisys Market Cap 2010-2025 | AMED

Amedisys market cap history and chart from 2010 to 2025. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Amedisys market cap as of May 23, 2025 is $3.07B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.066B $2.348B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.115B 18.84
Encompass Health (EHC) United States $11.985B 25.41
DaVita (DVA) United States $10.433B 14.67
Chemed (CHE) United States $8.332B 26.19
Elanco Animal Health (ELAN) United States $6.288B 13.47
Option Care Health (OPCH) United States $5.143B 22.93
RadNet (RDNT) United States $4.247B 269.57
LifeStance Health (LFST) United States $2.135B 0.00
Addus HomeCare (ADUS) United States $2.064B 22.66
Astrana Health (ASTH) United States $1.362B 33.74
U.S Physical Therapy (USPH) United States $1.123B 28.98
Aveanna Healthcare Holdings (AVAH) United States $1.038B 59.11
Pennant (PNTG) United States $0.957B 35.15
Atai Life Sciences (ATAI) Germany $0.413B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.043B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00